Skip to main content
Clinical Trials/CTRI/2024/01/061125
CTRI/2024/01/061125
Not yet recruiting
Phase 2

A Comparative Interventional Study to assess the efficacy of Intravenous Ketamine versus Oral Ketamine for patients with suicidal ideation - NI

A0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
A
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects aged 18 to 65 years with suicidal ideation having HAMD score more than or equal to 14 and Beck
  • suicidal ideation scale of more than or equal to 5
  • 2\. Subjects willing to take Ketamine after informed written consent.

Exclusion Criteria

  • 1\. Contraindication to the administration of ketamine, especially present diagnosis or
  • antecedents of clinically relevant cardiovascular disorders such as stroke, heart attack,
  • 2\. If they had any, those with present or past diagnosis of glaucoma, intracranial
  • hypertension.
  • 3\. Current diagnosis of schizophrenia or other psychotic disorder (including psychotic
  • disorder due to general medical condition, substance\-induced psychotic disorder, or
  • mania) as defined in the ICD\-11
  • 4\. Patients with any known hypersensitivity to ketamine.
  • 5\. Subjects having any substance dependence, intoxication or withdrawal within 1
  • month period

Outcomes

Primary Outcomes

Not specified

Similar Trials